Valiant Organics Board Meeting Outcome

Valiant Organics Other Announcement

The company has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.

Valiant Organics Legal & Regulatory

Valiant Organics received an income tax rectification order for Assessment Year 2015-16, determining a net payable amount of ₹0.22 Crore.

Value

₹0.22 Cr

Valiant Organics Investor Presentation: Key Takeaways

Valiant Organics presented its FY26 performance at the AGM, reporting Revenue of INR 739 Cr and EBITDA margin of 13.64%. The firm is shifting focus towards high-margin Benzene and Chlorophenol derivatives.

Valiant Organics Annual General Meeting

Valiant Organics held its 21st AGM on September 29, 2026, transacting various ordinary and special business items including re-appointments and material related party transaction approvals.

Valiant Organics Promoter Buying: ₹0 Cr

Promoter Vicky Hemchand Gala purchased 3,500 shares of Valiant Organics via a market transaction. This increases the promoter's stake by 0.01%.

Value

₹0.00 Cr

Promoter stake change

+0.01%

Valiant Organics Promoter Buying: ₹0.13 Cr

Promoter Vicky Hemchand Gala acquired 3,500 shares of Valiant Organics Ltd via a market purchase. This increases the promoter's holding from 0.92% to 0.93%.

Value

₹0.13 Cr

Promoter stake change

+0.01%

R R Kabel Board Meeting Outcome

RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.

M K Exim (India) Board Meeting Outcome

M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.

United Spirits Board Meeting Outcome

United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.

SBI Funds Management Board Meeting Outcome

SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.

Execution

April 1, 2028 to March 31, 2030

Paras Healthcare Board Meeting Outcome

Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.

Gateway Distriparks Board Meeting Outcome

Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.